A Phase I Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced or Metastatic Solid Tumors.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2015
At a glance
- Drugs BMS 817378 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Dec 2008 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 29 Nov 2008 New trial record.